0 results
0 results

Bringing reliability

and expertise to

clinical development

We are a Clinical Research Organisation with the commitment, expertise, and flexibility needed to deliver efficient clinical trials.

OUR SERVICES MODELS

As a Clinical Research Organization, Aixial Group collaborates with sponsors to develop oncology, cell & gene, and rare diseases therapies. We provide innovative solutions to overcome the challenges and complexities faced by global biotech and pharma companies. We advise you to choose the best model for your clinical research and development needs.

▶ Full-service partnership

Design and execution of full-service clinical trials

Aixial Group is a well-established, full-service CRO with experienced people and advanced technology for clinical data management.

Commitment to results

▶ Functional service provision

Formal Platform, FSP arrangement

We have extensive experience in governance, management, and partnership as an FSP provider. Our approach is tailored to your requirements and adapts as the partnership evolves.

Service level agreement

▶ Consulting support

Resources and Platform consulting support

We provide the clinical development capabilities and integrated consulting expertise needed to streamline development at every step, in a faster and more cost-effective way.

Commitment of resource

AREAS OF EXPERTISE

Our experience has enabled us to refine and evolve to incorporate the technology, processes, and insights necessary to ensure your clinical trial needs are future proof. Our approach gives us the flexibility to meet the ever changing needs of biotech and biopharma companies worldwide.

▶ Oncology

▶ Oncology

We strive to be a consultative and proactive oncology CRO partner. Our customized solutions are designed around the individual needs of each of our biopharma clients.
▶ Radiopharmaceuticals

▶ Radiopharmaceuticals

Our focus is to make sure sponsors are comfortable and confident from the start, aware of potential risks, and realistic about results.
▶ Rare diseases

▶ Rare diseases

With our experience, we know better than most that rare disease trials are different from any other. What may present as routine steps can have hidden challenges.
▶ Cell and Gene Therapy

▶ Cell and Gene Therapy

We understand the complexities of how to operationalise cell and gene therapy trials. Our teams and processes thrive on delivering results in a fast-paced landscape.
▶ Real World Evidence (RWE)

▶ Real World Evidence (RWE)

RWE generation requires the appropriate study design and analysis approach. Significant expertise in pharmacoepidemiology and biostatistics/data science is involved in the production, evaluation and interpretation of RWE.
▶ Other Therapeutic Specialty

▶ Other Therapeutic Specialty

Our expert’s deeper level of understanding across multiple disciplines with complex study designs, has provided sponsors with trial success.

Our CRO SOLUTIONS

As a Clinical Research Organisation, we specialise in applying both skills and technology to deliver well-managed trials in oncology, cell and gene therapy, and other rare diseases.

▶ Early Phase

▶ Early Phase

With our first-hand knowledge and expertise applied, we focus on safety while placing careful attention on each dose and patient need.
▶ Phase II / III CRO Services

▶ Phase II / III CRO Services

We have the solutions, people, and processes in place to successfully push your Phase II or Phase III clinical trial across the line.
▶ Decentralized Trials

▶ Decentralized Trials

We transform our sponsor’s synopsis into a fully rounded protocol with the maximum chance of success, carrying out detailed consideration, planning and management.
▶ Radiopharmaceutical Trials

▶ Radiopharmaceutical Trials

Our focus is to make sure sponsors are comfortable and confident from the start, aware of potential risks, and realistic about results.

How can we support your next project?

Contact us

What is happening in Aixial Group?

View all resources